©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110638
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110638
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110638
Table 2 Cox proportional hazards regression analysis of direct-acting antiviral intake and its association with variceal bleeding
| Variable | Mean survival (95%CI) | HR (95%CI) | P value |
| Group A | 4.5 (4.2-4.7) | 1 (Reference) | 0.002a |
| Group B | 3.2 (2.7-3.7) | 2.57 (1.39-4.72) |
- Citation: Abdel Hafez RS, Semeya AA, Elgamal R, Othman AA. Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study. World J Hepatol 2025; 17(11): 110638
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110638.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.110638